抗病毒药物研究进展及其在军事方面的应用

陆顺超; 阎澜

doi:10.3969/j.issn.1006-0111.2019.03.002

抗病毒药物研究进展及其在军事方面的应用

doi: 10.3969/j.issn.1006-0111.2019.03.002

陆顺超¹,
阎澜^2,

1.
海军军医大学基础医学院学员六大队学员十七队, 上海 200433
2.
海军军医大学药学院军特药研究中心, 上海 200433

Progress on anti-viral drugs and the application in military

LU Shunchao¹,
YAN Lan^2
,

1.
Company 17 of Cadet Battalion 6, College of Basic Medical Sciences, School of Pharmacy, Naval Medical University, Shanghai 200433, China
2.
Military Special Drug Research Center, School of Pharmacy, Naval Medical University, Shanghai 200433, China

摘要: 病毒感染威胁着人类健康，目前现有的抗病毒药物存在耐药性、毒副作用大等问题，因此，研发新型抗病毒药物仍是临床的迫切需求。针对多种不同抗病毒药物的研究和临床使用情况，根据药物不同的作用特点，分别介绍DNA多聚酶抑制剂、逆转录酶抑制剂、蛋白酶抑制剂、整合酶抑制剂、神经氨酸酶抑制剂、广谱抗菌药等临床常用及新型抗病毒药物，并简要介绍抗病毒药物在军事领域的应用。
- 抗病毒药物 /
- 免疫治疗 /
- 基因治疗
Abstract: Virus infection threatens human health.At present,the existing antiviral drugs have several problems including drug resistance and side effects.Thus,the study of new antiviral drugs has still become an urgent need in clinical practice.In this paper,some clinical commonly used and new antiviral drugs such as DNA polymerase inhibitor,reverse transcriptase inhibitor,protease inhibitor,integrase inhibitor,neuraminidase inhibitor,broad-spectrum antibacterial drugs and so on,were classified according to the different characteristics of antiviral drugs.This review also briefly introduced the application of antiviral drugs in military field.
- anti-viral drugs /
- immunotherapy /
- gene therapy

[1]	MARTINEZ J P,SASSE F,BRÖNSTRUP M M,et al.Antiviral drug discovery:broad-spectrum drugs from nature[J].Nat Prod Rep,2015,32(1):29-48.
[2]	WANG Y X,LI J X,HU Y M,et al.Ebola vaccines in clinical trial:the promising candidates[J].Human Vacc Immunother,2017,13(1):153-168.
[3]	杜红,赵柳红,覃忠于,等.HIV感染/AIDS住院患者高效抗逆转录病毒治疗中发生骨髓抑制致死亡的影响因素[J].中国药房,2015,26(35):4951-4954.
[4]	陈美钦,王长连.核苷类抗病毒药群体药动学研究及应用[J].海峡药学,2016,28(7):4-7.
[5]	DÉBORAH H,SAIK U,ELISABETH R,et al.Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates[J].Antimicrob Agent,2009,53(3):1067-1073.
[6]	ELION R,MOLINA J M,RAMN ARRIBAS LPEZ J,et al.A randomized phase 3 study comparing once-daily elvitegravir with twice-daily raltegravir in treatment-experienced subjects with HIV-1 infection[J].J AIDS,2013,63(4):494-497.
[7]	杨庆坤,龙燕,陈典颜,等.PEG-IFN α-2a和利巴韦林联合自拟中药复方治疗慢性丙型肝炎的临床疗效[J].重庆医学,2017,46(32):4533-4536.
[8]	戴兆东,经继生,赵伟.普通干扰素联合利巴韦林治疗1b型丙肝患者疗效分析[J].东南大学学报(医学版),2017,36(6):1002-1004.
[9]	KAMATA M,LIU S,LIANG M,et al.Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter[J].Human Gene Therap,2010,21(11):1555-1567.
[10]	REGULES J A,BEIGEL J H,PAOLINO K M,et al.A recombinant vesicular stomatitis virus Ebola vaccine[J].N Engl J Med,2017,376(4):330-341.
[11]	SHUCHMAN M.Ebola vaccine trial in west Africa faces criticism[J].Lancet,2015,385(9981):1933-1934.
[12]	Agnandji S T,Huttner A,Zinser M E,et al.Phase 1 trials of rVSV Ebola vaccine in Africa and Europe[J].N Engl J Med,2016,374(17):1647-1660.
[13]	MEDAGLINI D,HARANDI A M,OTTENHOFF T H M,et al.Ebola vaccine R&D:filling the knowledge gaps[J].Sci Transl Med,2015,7(317):317ps24.
[14]	FELDMANN H,JONES S M,DADDARIO-DICAPRIO K M,et al.Effective post-exposure treatment of Ebola infection[J].PLoS Pathogens,2007,3(1):e2.
[15]	JACOBS M,AARONS E,BHAGANI S,et al.Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents:a case-series of health-care workers[J].Lancet Infect Dis,2015,15(11):1300-1304.
[16]	LI A Z,YU J Y,LU M J,et al.A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein[J].Nat Commun,2018,9:3067.
[17]	李静,戎庭军,张铭键,等.TLR7的研究进展[J].浙江临床医学,2015(2):315-317.
[18]	HEMMI H,KAISHO T,TAKEUCHI O,et al.Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway[J].Nat Immunol,2002,3(2):196-200.
[19]	MARTIN H J,LEE J M,WALLS D,et al.Manipulation of the toll-like receptor 7 signaling pathway by epstein-barr virus[J].J Virol,2007,81(18):9748-9758.
[20]	SUNG J A,PATEL S,CLOHOSEY M L,et al.HIV-specific,Ex vivo expanded T cell therapy:feasibility,safety,and efficacy in ART-suppressed HIV-infected individuals[J].Molecul Ther,2018,26(10):2496-2506.
[21]	MENDOZA P,GRUELL H,NOGUEIRA L,et al.Combination therapy with anti-HIV-1 antibodies maintains viral suppression[J].Nature,2018,561(7724):479-484.
[22]	赵旭,周辛波,钟武,等.抗病毒药物——法匹拉韦[J].临床药物治疗杂志,2015,13(4):16-20.
[23]	SHI F,LI Z,KONG L,et al.Synthesis and crystal structure of 6-fluoro-3-hydroxypyrazine-2-carboxamide[J].Drug Discov Ther,2014,8(3):117-120.

[1]	夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞. 核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
[2]	陈怡君, 王卓, 何苗, 张宇, 田泾. 泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
[3]	张元林, 宋凯, 孙蕊, 舒飞, 舒丽芯, 杨樟卫. 基于真实世界数据的药物利用研究综述 . 药学实践与服务, 2024, 42(6): 238-243. doi: 10.12206/j.issn.2097-2024.202312010
[4]	桂明珠, 李静, 李志玲. 儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
[5]	黄韵, 张正银, 金英, 郑怡菁, 李铁军, 孙莉莉. 耐碳青霉烯类肺炎克雷伯菌及大肠埃希菌临床分离株耐药性及耐药基因分析 . 药学实践与服务, 2024, 42(10): 439-444. doi: 10.12206/j.issn.2097-2024.202309059
[6]	王雪莲, 郑斯莉, 李志勇, 罗亨宇, 缪朝玉. 全身过表达人METRNL基因小鼠模型的构建与验证 . 药学实践与服务, 2024, 42(5): 198-202, 222. doi: 10.12206/j.issn.2097-2024.202311014
[7]	顾佳钰, 胡馨儿, 王晓飞, 张颖, 张海, 曹岩. 侧流免疫层析定量检测方法的研究进展 . 药学实践与服务, 2024, 42(7): 273-277, 284. doi: 10.12206/j.issn.2097-2024.202307037
[8]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[9]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202401073
[10]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[11]	丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉. 消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
[12]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘患者的临床疗效观察 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202405035
[13]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[14]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[15]	陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼. 通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202404008
[16]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[17]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[18]	宋泽成, 陈林林, 鲁仁义, 刘梦肖, 王彦. 脓毒症治疗的研究进展 . 药学实践与服务, 2024, 42(11): 1-5. doi: 10.12206/j.issn.2097-2024.202405059
[19]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[20]	马兹芬, 许维恒, 金煜翔, 薛磊. 食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008

点击查看大图

计量

文章访问数: 3540
HTML全文浏览量: 405
PDF下载量: 587
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

抗病毒药物研究进展及其在军事方面的应用

doi: 10.3969/j.issn.1006-0111.2019.03.002

Progress on anti-viral drugs and the application in military

计量

抗病毒药物研究进展及其在军事方面的应用

doi: 10.3969/j.issn.1006-0111.2019.03.002

1. 海军军医大学基础医学院学员六大队学员十七队, 上海 200433

2. 海军军医大学药学院军特药研究中心, 上海 200433

English Abstract

Progress on anti-viral drugs and the application in military

1. Company 17 of Cadet Battalion 6, College of Basic Medical Sciences, School of Pharmacy, Naval Medical University, Shanghai 200433, China

2. Military Special Drug Research Center, School of Pharmacy, Naval Medical University, Shanghai 200433, China

全文HTML

目录

留言板

抗病毒药物研究进展及其在军事方面的应用

doi: 10.3969/j.issn.1006-0111.2019.03.002

Progress on anti-viral drugs and the application in military

计量

出版历程

抗病毒药物研究进展及其在军事方面的应用

doi: 10.3969/j.issn.1006-0111.2019.03.002

1. 海军军医大学 基础医学院学员六大队学员十七队, 上海 200433 2. 海军军医大学 药学院军特药研究中心, 上海 200433

English Abstract

Progress on anti-viral drugs and the application in military

1. Company 17 of Cadet Battalion 6, College of Basic Medical Sciences, School of Pharmacy, Naval Medical University, Shanghai 200433, China 2. Military Special Drug Research Center, School of Pharmacy, Naval Medical University, Shanghai 200433, China

全文HTML

目录

1. 海军军医大学基础医学院学员六大队学员十七队, 上海 200433

2. 海军军医大学药学院军特药研究中心, 上海 200433

1. Company 17 of Cadet Battalion 6, College of Basic Medical Sciences, School of Pharmacy, Naval Medical University, Shanghai 200433, China

2. Military Special Drug Research Center, School of Pharmacy, Naval Medical University, Shanghai 200433, China